Ovid Therapeutics
(NASDAQ) OVID
Ovid Therapeutics Financials at a Glance
Market Cap
$290.13M
Revenue (TTM)
$7.25M
Net Income (TTM)
$17.41M
EPS (TTM)
$-0.26
P/E Ratio
-8.38
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$2.19
Volume
49,480
Open
$2.15
Price
$2.19
Volume
49,480
Open
$2.15
Previous Close
$2.19
Daily Range
$2.09 - $2.21
52-Week Range
$0.24 - $2.72
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$2.19
Volume
49,480
Open
$2.15
Previous Close
$2.19
Daily Range
$2.09 - $2.21
52-Week Range
$0.24 - $2.72
OVID News
3 Top Biotech Stocks to Buy Now
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ovid Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
Jeremy Max Levin, MD, PhD
Website
www.ovidrx.comHeadquarters
New York City, NY 10036, US
OVID Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-6%
Net Income Margin
-2%
Return on Equity
-18%
Return on Capital
-30%
Return on Assets
-12%
Earnings Yield
-11.93%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$290.13M
Shares Outstanding
131.88M
Volume
49.48K
Short Interest
0.00%
Avg. Volume
2.55M
Financials (TTM)
Gross Profit
$6.95M
Operating Income
$42.44M
EBITDA
$42.14M
Operating Cash Flow
$38.33M
Capital Expenditure
$0.00
Free Cash Flow
$38.33M
Cash & ST Invst.
$69.64M
Total Debt
$13.42M
Ovid Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$718.00K
+844.7%
Gross Profit
$674.00K
+786.8%
Gross Margin
93.87%
N/A
Market Cap
$290.13M
N/A
Market Cap/Employee
$12.61M
N/A
Employees
23
N/A
Net Income
$9.66M
+204.4%
EBITDA
$12.29M
-14.2%
Quarterly Fundamentals
Net Cash
$56.22M
+46.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$11.99M
-10.7%
Short Term Debt
$1.43M
+7.3%
Return on Assets
-11.54%
N/A
Return on Invested Capital
-29.75%
N/A
Free Cash Flow
$10.41M
-3.8%
Operating Cash Flow
$10.41M
-4.0%